BFM
ALNY icon

Boothbay Fund Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Boothbay Fund Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-46,000
Closed -$11.2M – 1589
2024
Q2 		$11.2M Buy
46,000
+8,600
+23% +$1.36M 0.26% 57
2024
Q1 		$5.59M Buy
37,400
+13,000
+53% +$2.17M 0.11% 196
2023
Q4 		$4.67M Buy
+24,400
New +$4.16M 0.12% 222
2022
Q3 		– Sell
-4,700
Closed -$686K – 2214
2022
Q2 		$686K Sell
4,700
-9,100
-66% -$1.29M 0.02% 1006
2022
Q1 		$2.25M Buy
+13,800
New +$2.1M 0.05% 530
2021
Q3 		– Sell
-34,100
Closed -$5.78M – 1876
2021
Q2 		$5.78M Buy
+34,100
New +$4.99M 0.19% 117
2021
Q1 		– Sell
-57
Closed -$741K – 1508
2020
Q4 		$741K Hold
57
– – 0.03% 610
2020
Q3 		$830K Buy
+57
New +$8.1K 0.05% 488
2020
Q2 		– Sell
-90
Closed -$980K – 947
2020
Q1 		$980K Buy
+90
New +$10.4K 0.08% 304
2019
Q3 		– Sell
-192
Closed -$1.39M – 755
2019
Q2 		$1.39M Sell
192
-114
-37% -$8.75K 0.13% 197
2019
Q1 		$2.86M Buy
306
+95
+45% +$7.95K 0.28% 83
2018
Q4 		$1.54M Buy
+211
New +$16.2K 0.22% 88
2018
Q3 		– Sell
-107
Closed -$1.05M – 776
2018
Q2 		$1.05M Buy
+107
New +$10.6K 0.09% 173

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Boothbay Fund Management's ALNY Position: Q3 2025 in Review

Boothbay Fund Management sold out of Alnylam Pharmaceuticals (ALNY) in Q3 2025, closing a stake of 19,213 shares — an estimated $6.27M sold.

Boothbay Fund Management first reported a position in ALNY in Q2 2017 and held it in 11 quarters. The position peaked at $6.27M in Q2 2025. 822 funds tracked by Wall St. Rank hold ALNY as of Q3 2025.

  • Boothbay Fund Management reported no remaining Alnylam Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Boothbay Fund Management sold 19,213 Alnylam Pharmaceuticals shares in Q3 2025, an estimated $6.27M.
  • Boothbay Fund Management first reported a position in Alnylam Pharmaceuticals in Q2 2017 and held it in 11 quarters.
  • Boothbay Fund Management's Alnylam Pharmaceuticals position peaked at $6.27M in Q2 2025.
  • 822 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2025.

Based on Boothbay Fund Management's 13F filing for Q3 2025, filed 14 Nov 2025.